Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus.

Viswanathan K, Verweij MC, John N, Malouli D, Früh K.

PLoS One. 2017 Nov 9;12(11):e0187899. doi: 10.1371/journal.pone.0187899. eCollection 2017.

2.

Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.

Malouli D, Hansen SG, Nakayasu ES, Marshall EE, Hughes CM, Ventura AB, Gilbride RM, Lewis MS, Xu G, Kreklywich C, Whizin N, Fischer M, Legasse AW, Viswanathan K, Siess D, Camp DG 2nd, Axthelm MK, Kahl C, DeFilippis VR, Smith RD, Streblow DN, Picker LJ, Früh K.

J Clin Invest. 2014 May;124(5):1928-44. Epub 2014 Apr 1.

3.

Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.

Viswanathan K, Bot I, Liu L, Dai E, Turner PC, Togonu-Bickersteth B, Richardson J, Davids JA, Williams JM, Bartee MY, Chen H, van Berkel TJ, Biessen EA, Moyer RW, Lucas AR.

PLoS One. 2012;7(9):e44694. doi: 10.1371/journal.pone.0044694. Epub 2012 Sep 26.

4.

Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Malouli D, Nakayasu ES, Viswanathan K, Camp DG 2nd, Chang WL, Barry PA, Smith RD, Früh K.

J Virol. 2012 Sep;86(17):8959-73. doi: 10.1128/JVI.01132-12. Epub 2012 Jun 20.

5.

BST2/Tetherin enhances entry of human cytomegalovirus.

Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Früh K.

PLoS Pathog. 2011 Nov;7(11):e1002332. doi: 10.1371/journal.ppat.1002332. Epub 2011 Nov 3.

6.

MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation.

Eyster CA, Cole NB, Petersen S, Viswanathan K, Früh K, Donaldson JG.

Mol Biol Cell. 2011 Sep;22(17):3218-30. doi: 10.1091/mbc.E10-11-0874. Epub 2011 Jul 14.

7.

Detection of altered extracellular matrix in surface layers of unstable carotid plaque: an optical spectroscopy, birefringence and microarray genetic analysis.

Korol RM, Canham PB, Liu L, Viswanathan K, Ferguson GG, Hammond RR, Finlay HM, Baker HV, Lopez C, Lucas AR.

Photochem Photobiol. 2011 Sep-Oct;87(5):1164-72. doi: 10.1111/j.1751-1097.2011.00960.x. Epub 2011 Jul 28.

PMID:
21699546
8.

Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes.

Bartee E, Eyster CA, Viswanathan K, Mansouri M, Donaldson JG, Früh K.

PLoS One. 2010 Dec 2;5(12):e15132. doi: 10.1371/journal.pone.0015132.

9.

Viral hijacking of the host ubiquitin system to evade interferon responses.

Viswanathan K, Früh K, DeFilippis V.

Curr Opin Microbiol. 2010 Aug;13(4):517-23. doi: 10.1016/j.mib.2010.05.012. Epub 2010 Jun 17. Review.

10.

The great escape: viral strategies to counter BST-2/tetherin.

Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, Früh K.

PLoS Pathog. 2010 May 13;6(5):e1000913. doi: 10.1371/journal.ppat.1000913. Review.

11.

The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.

Lucas A, Liu L, Dai E, Bot I, Viswanathan K, Munuswamy-Ramunujam G, Davids JA, Bartee MY, Richardson J, Christov A, Wang H, Macaulay C, Poznansky M, Zhong R, Miller L, Biessen E, Richardson M, Sullivan C, Moyer R, Hatton M, Lomas DA, McFadden G.

Adv Exp Med Biol. 2009;666:132-56. Review.

PMID:
20054981
12.

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.

Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, Moses AV, Früh K.

J Virol. 2009 Oct;83(19):9672-81. doi: 10.1128/JVI.00597-09. Epub 2009 Jul 15.

13.

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, Moses AV.

J Virol. 2009 Aug;83(16):7931-47. doi: 10.1128/JVI.00242-09. Epub 2009 Jun 10.

14.

Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.

Viswanathan K, Richardson J, Togonu-Bickersteth B, Dai E, Liu L, Vatsya P, Sun YM, Yu J, Munuswamy-Ramanujam G, Baker H, Lucas AR.

J Leukoc Biol. 2009 Mar;85(3):418-26. doi: 10.1189/jlb.0808506. Epub 2008 Dec 3.

PMID:
19052145
15.

Viral proteomics: global evaluation of viruses and their interaction with the host.

Viswanathan K, Früh K.

Expert Rev Proteomics. 2007 Dec;4(6):815-29. Review.

PMID:
18067418
16.

Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.

Richardson M, Liu L, Dunphy L, Wong D, Sun Y, Viswanathan K, Singh G, Lucas A.

Cardiovasc Pathol. 2007 Jul-Aug;16(4):191-202. Epub 2007 Apr 11.

PMID:
17637427
17.

C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity.

Bocksch L, Rider BJ, Stephens T, Dai E, Liu L, Diao H, Viswanathan K, Munuswamy-Ramanujam G, Singh B, Lucas A.

Atherosclerosis. 2007 Sep;194(1):116-24. Epub 2006 Nov 28.

PMID:
17126342
18.

Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.

Viswanathan K, Liu L, Vaziri S, Dai E, Richardson J, Togonu-Bickersteth B, Vatsya P, Christov A, Lucas AR.

Thromb Haemost. 2006 Mar;95(3):499-510.

PMID:
16525579
19.

Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses.

Dai E, Viswanathan K, Sun YM, Li X, Liu LY, Togonu-Bickersteth B, Richardson J, Macaulay C, Nash P, Turner P, Nazarian SH, Moyer R, McFadden G, Lucas AR.

J Biol Chem. 2006 Mar 24;281(12):8041-50. Epub 2006 Jan 9.

20.

Serpins, the vasculature, and viral therapeutics.

Richardson J, Viswanathan K, Lucas A.

Front Biosci. 2006 Jan 1;11:1042-56. Review.

PMID:
16146796

Supplemental Content

Loading ...
Support Center